Variants Affecting Exon Skipping Contribute to Complex Traits

PLoS Genetics

Volumn 8, Issue 10, 2012, Pages

  Lee, Younghee ^a   Gamazon, Eric R ^a   Rebman, Ellen ^a   Lee, Yeunsook ^b   Lee, Sanghyuk ^c   Dolan, M Eileen ^a   Cox, Nancy J ^a   Lussier, Yves A ^a,d  

^a UNIVERSITY OF CHICAGO   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c Ewha Womans University   (South Korea)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER MODEL; EXON SKIPPING; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC TRAIT; GENETIC VARIABILITY; HIGH THROUGHPUT SEQUENCING; HUMAN; INTRON; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALTERNATIVE SPLICING; COMPUTATIONAL BIOLOGY; CYCLIN-DEPENDENT KINASES; EXONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; MODELS, MOLECULAR; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN CONFORMATION; PROTEINS; QUANTITATIVE TRAIT LOCI; QUANTITATIVE TRAIT, HERITABLE; RNA ISOFORMS;

EID: 84868120556     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002998     Document Type: Article

References (69)

1. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, et al.(2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302: 2141-2144.
2. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, et al.(2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476.
3. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ, (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature genetics 40: 1413-1415.
4. Graveley BR, Brooks AN, Carlson JW, Duff MO, Landolin JM, et al.(2011) The developmental transcriptome of Drosophila melanogaster. Nature 471: 473-479.
5. Gabut M, Samavarchi-Tehrani P, Wang X, Slobodeniuc V, O'Hanlon D, et al.(2011) An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 147: 132-146.
6. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, et al.(2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nature neuroscience 14: 459-468.
7. Venables JP, Klinck R, Koh C, Gervais-Bird J, Bramard A, et al.(2009) Cancer-associated regulation of alternative splicing. Nature structural & molecular biology 16: 670-676.
8. Barash Y, Calarco JA, Gao W, Pan Q, Wang X, et al.(2010) Deciphering the splicing code. Nature 465: 53-59.
9. Gaildrat P, Krieger S, Thery JC, Killian A, Rousselin A, et al.(2010) The BRCA1 c.5434C→G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements. Journal of medical genetics 47: 398-403.
10. Venables JP, (2004) Aberrant and alternative splicing in cancer. Cancer research 64: 7647-7654.
11. Lefave CV, Squatrito M, Vorlova S, Rocco GL, Brennan CW, et al.(2011) Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas. The EMBO journal 30: 4084-4097.
12. Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, et al.(2011) An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 7: e1002218 doi:10.1371/journal.pgen.1002218.
13. Allende-Vega N, Dayal S, Agarwala U, Sparks A, Bourdon JC, et al.(2012) p53 is activated in response to disruption of the pre-mRNA splicing machinery. Oncogene.
14. Yu Y, Maroney PA, Denker JA, Zhang XH, Dybkov O, et al.(2008) Dynamic regulation of alternative splicing by silencers that modulate 5′ splice site competition. Cell 135: 1224-1236.
15. Heinzen EL, Ge D, Cronin KD, Maia JM, Shianna KV, et al.(2008) Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol 6: e1000001 doi:10.1371/journal.pbio.1000001.
16. Yin H, Lu Q, Wood M, (2008) Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice. Mol Ther 16: 38-45.
17. Mitrpant C, Adams AM, Meloni PL, Muntoni F, Fletcher S, et al.(2009) Rational design of antisense oligomers to induce dystrophin exon skipping. Mol Ther 17: 1418-1426.
18. van Deutekom JC, Janson AA, Ginjaar IB, Frankhuizen WS, Aartsma-Rus A, et al.(2007) Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 357: 2677-2686.
19. Medina MW, Krauss RM, (2009) The role of HMGCR alternative splicing in statin efficacy. Trends Cardiovasc Med 19: 173-177.
20. DiFeo A, Feld L, Rodriguez E, Wang C, Beer DG, et al.(2008) A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response. Cancer Res 68: 965-970.
21. Narla G, Difeo A, Reeves HL, Schaid DJ, Hirshfeld J, et al.(2005) A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res 65: 1213-1222.
22. Caceres JF, Kornblihtt AR, (2002) Alternative splicing: multiple control mechanisms and involvement in human disease. Trends in genetics: TIG 18: 186-193.
23. Cartegni L, Chew SL, Krainer AR, (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3: 285-298.
24. Faustino NA, Cooper TA, (2003) Pre-mRNA splicing and human disease. Genes & development 17: 419-437.
25. Pagani F, Baralle FE, (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nature reviews Genetics 5: 389-396.
26. Sterne-Weiler T, Howard J, Mort M, Cooper DN, Sanford JR, (2011) Loss of exon identity is a common mechanism of human inherited disease. Genome research 21: 1563-1571.
27. Kwan T, Benovoy D, Dias C, Gurd S, Provencher C, et al.(2008) Genome-wide analysis of transcript isoform variation in humans. Nat Genet 40: 225-231.
28. Pickrell JK, Marioni JC, Pai AA, Degner JF, Engelhardt BE, et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464: 768-772.
29. Cirulli ET, Singh A, Shianna KV, Ge D, Smith JP, et al.(2010) Screening the human exome: a comparison of whole genome and whole transcriptome sequencing. Genome Biol 11: R57.
30. Duan S, Huang RS, Zhang W, Bleibel WK, Roe CA, et al.(2008) Genetic architecture of transcript-level variation in humans. American journal of human genetics 82: 1101-1113.
31. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al.(2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362-9367.
32. Yeo G, Hoon S, Venkatesh B, Burge CB, (2004) Variation in sequence and organization of splicing regulatory elements in vertebrate genes. Proc Natl Acad Sci U S A 101: 15700-15705.
33. Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, et al.(2010) SCAN: SNP and copy number annotation. Bioinformatics 26: 259-262.
34. Bowcock AM, Krueger JG, (2005) Getting under the skin: the immunogenetics of psoriasis. Nature reviews Immunology 5: 699-711.
35. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, et al.(2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467: 832-838.
36. Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, et al.(2009) Genome-wide association study identifies three loci associated with melanoma risk. Nature genetics 41: 920-925.
37. Flicek P, Amode MR, Barrell D, Beal K, Brent S, et al.(2011) Ensembl 2011. Nucleic acids research 39: D800-806.
38. Graveley BR, (2009) Alternative splicing: regulation without regulators. Nat Struct Mol Biol 16: 13-15.
39. Baraniak AP, Chen JR, Garcia-Blanco MA, (2006) Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice. Molecular and cellular biology 26: 1209-1222.
40. Fagnani M, Barash Y, Ip JY, Misquitta C, Pan Q, et al.(2007) Functional coordination of alternative splicing in the mammalian central nervous system. Genome biology 8: R108.
41. Huh GS, Hynes RO, (1994) Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element. Genes & development 8: 1561-1574.
42. Jin Y, Suzuki H, Maegawa S, Endo H, Sugano S, et al.(2003) A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. The EMBO journal 22: 905-912.
43. Lim LP, Sharp PA, (1998) Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats. Molecular and cellular biology 18: 3900-3906.
44. Minovitsky S, Gee SL, Schokrpur S, Dubchak I, Conboy JG, (2005) The splicing regulatory element, UGCAUG, is phylogenetically and spatially conserved in introns that flank tissue-specific alternative exons. Nucleic acids research 33: 714-724.
45. Ponthier JL, Schluepen C, Chen W, Lersch RA, Gee SL, et al.(2006) Fox-2 splicing factor binds to a conserved intron motif to promote inclusion of protein 4.1R alternative exon 16. The Journal of biological chemistry 281: 12468-12474.
46. Underwood JG, Boutz PL, Dougherty JD, Stoilov P, Black DL, (2005) Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. Molecular and cellular biology 25: 10005-10016.
47. Zhang W, Liu H, Han K, Grabowski PJ, (2002) Region-specific alternative splicing in the nervous system: implications for regulation by the RNA-binding protein NAPOR. RNA 8: 671-685.
48. Zhu H, Hasman RA, Young KM, Kedersha NL, Lou H, (2003) U1 snRNP-dependent function of TIAR in the regulation of alternative RNA processing of the human calcitonin/CGRP pre-mRNA. Molecular and cellular biology 23: 5959-5971.
49. Genetta T, Morisaki H, Morisaki T, Holmes EW, (2001) A novel bipartite intronic splicing enhancer promotes the inclusion of a mini-exon in the AMP deaminase 1 gene. The Journal of biological chemistry 276: 25589-25597.
50. Guo N, Kawamoto S, (2000) An intronic downstream enhancer promotes 3′ splice site usage of a neural cell-specific exon. The Journal of biological chemistry 2000/08/10 ed pp. 33641-33649.
51. Liu S, Altman RB, (2003) Large scale study of protein domain distribution in the context of alternative splicing. Nucleic acids research 31: 4828-4835.
52. Lewis BP, Green RE, Brenner SE, (2003) Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proceedings of the National Academy of Sciences of the United States of America 100: 189-192.
53. Alekseyenko AV, Kim N, Lee CJ, (2007) Global analysis of exon creation versus loss and the role of alternative splicing in 17 vertebrate genomes. RNA 13: 661-670.
54. Sugnet CW, Kent WJ, Ares M Jr, Haussler D, (2004) Transcriptome and genome conservation of alternative splicing events in humans and mice. Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing pp. 66-77.
55. Ha K, Coulombe-Huntington J, Majewski J, (2009) Comparison of Affymetrix Gene Array with the Exon Array shows potential application for detection of transcript isoform variation. BMC genomics 10: 519.
56. Nica AC, Parts L, Glass D, Nisbet J, Barrett A, et al.(2011) The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet 7: e1002003 doi:10.1371/journal.pgen.1002003.
57. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, et al. The UCSC Genome Browser database: update 2011. Nucleic acids research 39: D876-882.
58. Kuhn RM, Karolchik D, Zweig AS, Wang T, Smith KE, et al.(2009) The UCSC Genome Browser Database: update 2009. Nucleic acids research 37: D755-761.
59. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL, (2004) GenBank: update. Nucleic acids research 32: D23-26.
60. Hubbard T, Barker D, Birney E, Cameron G, Chen Y, et al.(2002) The Ensembl genome database project. Nucleic acids research 30: 38-41.
61. Thierry-Mieg D, Thierry-Mieg J, (2006) AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7 (Suppl 1): S12 11-14.
62. Hsu F, Kent WJ, Clawson H, Kuhn RM, Diekhans M, et al.(2006) The UCSC Known Genes. Bioinformatics 22: 1036-1046.
63. Kent WJ, (2002) BLAT-the BLAST-like alignment tool. Genome Res 12: 656-664.
64. Zhang W, Duan S, Bleibel WK, Wisel SA, Huang RS, et al.(2009) Identification of common genetic variants that account for transcript isoform variation between human populations. Human genetics 125: 81-93.
65. Inc A, (2006) Identifying and validating alternative splicing events. Affymetrix Technical Note.
66. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, et al.(2010) Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 6: e1000888 doi:10.1371/journal.pgen.1000888.
67. Storey JD, Tibshirani R, (2003) Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America 100: 9440-9445.
68. Roy A, Kucukural A, Zhang Y, (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nature protocols 5: 725-738.
69. Zhang Y, Skolnick J, (2005) TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic acids research 33: 2302-2309.